Tissue engineering is increasingly being recognized as a beneficial means for lessening the global disease burden. For example, novel methods for pancreatic islet regeneration can address diabetes; autologous cells for heart muscle regeneration can address coronary artery disease; and nerve regeneration technologies can be utilized to treat stroke. This course will describe strategies of tissue engineering, and will focus on the diseases that tissue engineering can address. Each lecture will identify a specific disease process (coronary artery disease, stroke, diabetes, etc.) and describe tissue engineered scaffolds that can alleviate the disease. Students will learn the underlying pathology of the disease; understand the latest advances in tissue engineering for treating the disease; and discuss prospective research areas for novel biomaterials to modify the disease process. In addition, students will gain an appreciation for clinical trials of tissue engineered scaffolds, as well as commercialization of tissue engineering.